The Department of Veterans Affairs Veterans Health Administration awarded a blanket purchase agreement to Tosoh Bioscience, Inc. for continuous positive pressure room analyzers, laboratory critical analyzers, and related services. Awards were issued against the Critical Analyzers, Laboratory Federal Supply Schedule with a potential total value exceeding $207,000. Performance will take place in South San Francisco, California through September 2022.
The BPA calls support VHA's efforts to monitor hemoglobin A1c levels, a key indicator of blood glucose management, for veterans receiving care within multiple integrated service networks. Tosoh Bioscience will provide continuous point-of-care testing equipment, reagents, and clinical diagnostic services to enable A1C screening and analysis at various VA medical facilities. The analyzers and supplies procured under this IDV aim to help the agency effectively track glycemic control and cardiovascular risk among patient populations, consistent with its healthcare programs.
Generated 1/4/24, 7:08 PM